BioCentury
ARTICLE | Company News

University of Minnesota, Oxis deal

September 28, 2015 7:00 AM UTC

Two researchers at the university granted Oxis exclusive, worldwide rights to develop and commercialize DT2219ARL. The researchers will receive an upfront payment and are eligible for milestones, plus royalties. ...